Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 5, keine Gesamtzahl für „safety“
Suchtreffer
Begriffe & Kennungen
Afqlir · 4.8 · The safety data described below include all adverse reactions from the eight phase III studies in the indicati
Eintrag öffnenAfstyla · 4.8 · Summary of the safety profile Hypersensitivity or allergic reactions (which may include angioedema, burning an
Eintrag öffnenAhzantive · 4.8 · 7 The safety data described below include all adverse reactions from the eight phase III studies in the indica
Eintrag öffnenAhzantive · 4.8 · A total of 3,102 patients constituted the safety population in the eight phase III studies. Among those, 2,501
Eintrag öffnenAhzantive · 4.8 · A total of 3,102 patients constituted the safety population in the eight phase III studies. Among those, 2,501
Eintrag öffnenAhzantive · 4.8 · Summary of the safety profile
Eintrag öffnenAhzantive · 4.8 · Summary of the safety profile
Eintrag öffnenAhzantive · 4.8 · The safety data described below include all adverse reactions from the eight phase III studies in the indicati
Eintrag öffnenAimovig · 4.8 · Summary of the safety profile
Eintrag öffnenAjovy · 4.8 · Summary of the safety profile
Eintrag öffnenAkeega · 4.8 · Summary of the safety profile The overall safety profile of Akeega is based on pooled data from two clinical P
Eintrag öffnenAkynzeo · 4.8 · Summary of the safety profile
Eintrag öffnenAkynzeo · 4.8 · Summary of the safety profile
Eintrag öffnenAkynzeo · 4.8 · Summary of the safety profile
Eintrag öffnenAkynzeo · 4.8 · Summary of the safety profile
Eintrag öffnenAkynzeo · 4.8 · The safety profile of Akynzeo 235 mg/0.25 mg concentrate for solution for infusion was similar to that seen wi
Eintrag öffnenAkynzeo · 4.8 · The safety profile of Akynzeo 235 mg/0.25 mg powder for concentrate for solution for infusion was similar to t
Eintrag öffnenAldurazyme · 4.8 · Summary of the safety profile The majority of the related adverse events in the clinical trials were classifie
Eintrag öffnenAlecensa · 4.8 · Summary of the safety profile
Eintrag öffnenAlimta · 4.8 · Summary of the safety profile
Eintrag öffnen